e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Cosio M.G.
Source:
Eur Respir J 2004; 24: 3-5
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cosio M.G.. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 3-5
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 78-85
Year: 2004
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002
Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 359s
Year: 2003
IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Decreased TCR γδ T lymphocytes in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003
Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
Erythropoietin dysregulation in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept